For those with hypermobility and EDS specifically, Id flag the following as the minimum due diligence before starting these medications: A thorough GI history and ideally gastric emptying assessment if theres any existing dysmotility Baseline muscle mass measurement (DEXA or similar) given the sarcopenia risk A clear plan for high-protein diet and resistance-based exercise to mitigate muscle loss Baseline bone density if theres any existing concern Consideration of the nutritional picture specific to hypermobility, since these drugs can affect appetite and nutrient absorption A conversation specifically about MCAS if thats a feature of your presentation The medication options for hypermobility and EDS are limited and often unsatisfying, and its entirely understandable why people are looking at something new with genuine curiosity
Here are some pro tips to help you get the most out of your journey: Eat Slowly and Mindfully: Semaglutide makes you feel full faster
When taken alongside propranolol, which blocks beta receptors, the unopposed alpha-adrenergic stimulation from these decongestants can cause a marked increase in blood pressure potentially severe in some individuals
4.5 ROS-responsive hydrogels ROS levels in chronic wound sites are high, and ROS-responsive hydrogels can be designed according to these characteristics to achieve intelligent release of drugs and thus improve the therapeutic effect
13 (624), eabg8116
Lamers F, Milaneschi Y, Vinkers CH, Schoevers RA, Giltay EJ, Penninx BWJH